X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.85
Delayed Data
As of 2:04pm ET
 0.00 / 0.00%
Today’s Change
1.84
Today|||52-Week Range
4.14
-19.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash2.0M6.7M6.3M6.1M
 
 
 
 
 
Cash & Short Term Investments2.4M6.7M6.3M6.1M
 
 
 
 
 
 
ReceivablesReceivables190.8K------
 
 
 
InventoriesInventories0.00--------
 
Current AssetsPrepaid Expenses129.9K------
 
 
Other Current Assets0.00649.4K466.6K358.6K
 
 
 
 
Current Assets2.8M7.4M6.8M6.4M
 
 
 
 
 
 
Total AssetsIntangible Assets252.8K------
 
 
Other Assets252.8K389.0K379.7K380.6K
 
 
 
 
 
Total Assets3.0M7.8M7.2M6.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable17.0K------
 
 
Accrued Expenses269.7K------
 
 
Other Current Liabilities269.7K542.6K381.7K285.7K
 
 
 
 
 
Other Liabilities329.7K542.6K381.7K285.7K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities0.003.7M4.7M2.9M
 
 
 
 
Total Liabilities329.7K4.3M5.1M3.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.00----0.00--
Common Equity2.7M3.5M2.1M3.6M
 
 
 
 
 
Total Shareholder Equity2.7M3.5M2.1M3.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.7M5.1M5.1M5.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.